跳至主要内容
临床试验/NCT06913075
NCT06913075尚未招募不适用

Is GnRH Agonist Plus Letrozole a Better Choice Than GnRH Agonist Alone in Adenomyosis Cases Undergoing Frozen Embryo Transfer?

Indira IVF Hospital Pvt Ltd1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2026年6月25日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
700
试验地点
1
主要终点
Ongoing pregnancy rate

研究概览

简要总结

Purpose of the Study:

To compare the effectiveness of GnRH agonist downregulation alone versus GnRH agonist combined with letrozole in improving pregnancy outcomes in women with adenomyosis undergoing frozen embryo transfer (FET).

Research Question:

Is the combined use of GnRH agonist and letrozole more effective than GnRH agonist downregulation alone in achieving better ongoing pregnancy rates in adenomyosis cases undergoing FET?

Hypothesis:

Null Hypothesis (H₀): The combined use of GnRH agonist and letrozole is not more effective than GnRH agonist downregulation alone in achieving a higher ongoing pregnancy rate in adenomyosis cases undergoing FET.

Study Outcomes:

Primary Outcome: Ongoing pregnancy rate at 12 weeks of gestation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Diagnosis of adenomyosis confirmed via transvaginal ultrasound as per MUSA criteria History of infertility requiring frozen embryo transfer (FET). Availability of at least one good-quality frozen embryo for transfer

排除标准

  • BMI ≥ 30 kg/m2 Presence of endocrine disorders; (uncontrolled diabetes mellitus, / hyperprolactinemia, thyroid dysfunction, Congenital adrenal hyperplasia, Cushing syndrome, or polycystic ovary syndrome Previous major uterine surgery Gestational carrier Fertility preservation

研究组 & 干预措施

Group A

Active Comparator

干预措施: GnRH agonist downregulation (Drug)

Group B

Active Comparator

干预措施: GnRH agonist and Letrozole (Drug)

结局指标

主要结局

Ongoing pregnancy rate

时间窗: 12 weeks of gestation

Presence of gestational sacs with a heartbeat at the 12th gestational week. The ongoing pregnancy rate will be calculated using the below formula. Ongoing pregnancy rate: (the number of ongoing pregnancy cases/the number of clinical pregnancy cases) × 100%

次要结局

  • Chemical Pregnancy rate(4 weeks after embryo transfer)
  • 1st trimester loss(12 weeks of gestation)
  • Live Birth Rate(Post delivery after completion of 20 weeks of gestation)
  • Implantation Rate(4 weeks after embryo transfer)
  • Biochemical loss rate(4 weeks after embryo transfer)
  • 2nd trimester loss(20 weeks of gestation)

研究者

发起方
Indira IVF Hospital Pvt Ltd
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

FET in Adenomyosis | 临床试验